Telehealth provider defies TGA semaglutide request Eucalyptus is reportedly offering patients access to the type 2 diabetes-indicated drug for weight loss purposes, despite ongoing supply issues.
Psychedelic prescribing to begin for PTSD and depression Experts are split on whether Australia is prepared for psychedelic-assisted therapy, but GPs need to be ready to answer questions and refer patients.
GP aged care standards launched for the first time New college standards set out ‘minimum requirements’ to provide high-quality care in residential aged care homes.
‘A very challenging space’: Opioid deprescribing guide released Work for guidelines was led by researchers at the University of Sydney and includes 11 recommendations with general practice in mind.
TGA’s vaping crackdown a sign of things to come The medicines regulator issued infringement notices to four entities this week, totalling almost $600,000.
TGA issues oral anticoagulants warning Reports of serious kidney damage in rare circumstances have prompted a class-wide update to the medications’ product information.
Warning over fake semaglutide Counterfeit products are being illegally imported into Australia, TGA testing has revealed.
TGA confirms reduced paracetamol pack sizes The changes, due to come into effect from February 2025, are aimed at reducing Australian overdose and death numbers.
Changes made to COVID Vaccine Claims Scheme The Department of Health and Aged Care has removed and added certain conditions that can be claimed in relation to COVID vaccine adverse reactions.
Debate over ‘doctor-approved’ weight loss drugs obtained online Is a GP-reviewed online questionnaire clinically sufficient to safely prescribe injectable medications without a face-to-face consultation? It depends who you ask.